JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on June 8, 2001
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
276/24/21489    most recent
M009382200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lovshin, J.
Right arrow Articles by Drucker, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lovshin, J.
Right arrow Articles by Drucker, D. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print March 21, 2001
J. Biol. Chem, 10.1074/jbc.M009382200
Submitted on October 13, 2000
Revised on March 19, 2001
Accepted on March 20, 2001

Glucagon-like peptide-2 action in the murine central nervous system is enhanced by elimination of GLP-1 receptor signaling

Julie Lovshin, Jen Estall, Bernardo Yusta, Theodore J. Brown, and Daniel J. Drucker

Department of Medicine, Toronto General Hospital, Toronto, Ontario M5G2C4

Corresponding Author: d.drucker{at}utoronto.ca

Glucagon-like peptide-2 (GLP-2) is expressed in gut endocrine cells where it regulates energy homeostasis via effects on nutrient absorption, and maintenance of mucosal epithelial integrity. The biological actions of GLP-2 in the central nervous system (CNS) remain poorly understood. We studied the sites of endogenous GLP-2 receptor (GLP-2R) expression, the localization of transgenic LacZ expression under the control of the mouse GLP-2R promoter and the biological actions of GLP-2 in the murine CNS. GLP-2R expression was detected in multiple extrahypothalamic regions of the mouse and rat CNS including cell groups in the cerebellum, medulla, amygdala, hippocampus, dentate gyrus, pons, cerebral cortex and pituitary. A 1.5-kilo base-pair fragment of the mouse GLP-2R promoter directed LacZ expression to the gastrointestinal tract and CNS regions in the mouse that exhibited endogenous GLP-2R expression including the cerebellum, amygdala, hippocampus and dentate gyrus. Intracerebroventricular injection of GLP-2 significantly inhibited food intake during dark phase feeding in wildtype mice. Disruption of glucagon-like peptide-1 (GLP-1) receptor signaling with the antagonist exendin (9-39) in wildtype mice, or genetically in GLP-1 receptor -/- mice, significantly potentiated the anorectic actions of GLP-2. These findings illustrate that CNS GLP-2R expression is not restricted to hypothalamic nuclei, and demonstrate that the anorectic effects of GLP-2 are transient and modulated by the presence or absence of GLP-1 receptor signaling in vivo.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
EndocrinologyHome page
F. Yi, J. Sun, G. E. Lim, I. G. Fantus, P. L. Brubaker, and T. Jin
Cross Talk between the Insulin and Wnt Signaling Pathways: Evidence from Intestinal Endocrine L Cells
Endocrinology, May 1, 2008; 149(5): 2341 - 2351.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. C. McDonagh, J. Lee, A. Izzo, and P. L. Brubaker
Role of glial cell-line derived neurotropic factor family receptor {alpha}2 in the actions of the glucagon-like peptides on the murine intestine
Am J Physiol Gastrointest Liver Physiol, August 1, 2007; 293(2): G461 - G468.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
P. E. Dube and P. L. Brubaker
Frontiers in glucagon-like peptide-2: multiple actions, multiple mediators
Am J Physiol Endocrinol Metab, August 1, 2007; 293(2): E460 - E465.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. L. Estall and D. J. Drucker
Tales beyond the Crypt: Glucagon-Like Peptide-2 and Cytoprotection in the Intestinal Mucosa
Endocrinology, January 1, 2005; 146(1): 19 - 21.
[Full Text] [PDF]


Home page
Mol. Biol. CellHome page
J. L. Estall, B. Yusta, and D. J. Drucker
Lipid Raft-dependent Glucagon-like Peptide-2 Receptor Trafficking Occurs Independently of Agonist-induced Desensitization
Mol. Biol. Cell, August 1, 2004; 15(8): 3673 - 3687.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. A. Lovshin, Q. Huang, R. Seaberg, P. L. Brubaker, and D. J. Drucker
Extrahypothalamic Expression of the Glucagon-Like Peptide-2 Receptor Is Coupled to Reduction of Glutamate-Induced Cell Death in Cultured Hippocampal Cells
Endocrinology, July 1, 2004; 145(7): 3495 - 3506.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. L. Brubaker and D. J. Drucker
Minireview: Glucagon-Like Peptides Regulate Cell Proliferation and Apoptosis in the Pancreas, Gut, and Central Nervous System
Endocrinology, June 1, 2004; 145(6): 2653 - 2659.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
A. Ramsanahie, M. S. Duxbury, T. C. Grikscheit, A. Perez, D. B. Rhoads, J. Gardner-Thorpe, J. Ogilvie, S. W. Ashley, J. P. Vacanti, and E. E. Whang
Effect of GLP-2 on mucosal morphology and SGLT1 expression in tissue-engineered neointestine
Am J Physiol Gastrointest Liver Physiol, December 1, 2003; 285(6): G1345 - G1352.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. L. Estall and D. J. Drucker
Dual Regulation of Cell Proliferation and Survival via Activation of Glucagon-Like Peptide-2 Receptor Signaling
J. Nutr., November 1, 2003; 133(11): 3708 - 3711.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
N. A. Walsh, B. Yusta, M. P. DaCambra, Y. Anini, D. J. Drucker, and P. L. Brubaker
Glucagon-Like Peptide-2 Receptor Activation in the Rat Intestinal Mucosa
Endocrinology, October 1, 2003; 144(10): 4385 - 4392.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
K. E. Mayo, L. J. Miller, D. Bataille, S. Dalle, B. Goke, B. Thorens, and D. J. Drucker
International Union of Pharmacology. XXXV. The Glucagon Receptor Family
Pharmacol. Rev., March 1, 2003; 55(1): 167 - 194.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Ni, Y. Anini, X. Fang, G. Mills, P. L Brubaker, and T. Jin
Transcriptional Activation of the Proglucagon Gene by Lithium and beta -Catenin in Intestinal Endocrine L Cells
J. Biol. Chem., January 3, 2003; 278(2): 1380 - 1387.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
D J Drucker
Gut adaptation and the glucagon-like peptides
Gut, March 1, 2002; 50(3): 428 - 435.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Bjerknes and H. Cheng
Modulation of specific intestinal epithelial progenitors by enteric neurons
PNAS, September 19, 2001; (2001) 211278098.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Bjerknes and H. Cheng
Modulation of specific intestinal epithelial progenitors by enteric neurons
PNAS, October 23, 2001; 98(22): 12497 - 12502.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.